Details for Patent: 8,513,263
Which drugs does patent 8,513,263 protect, and when does it expire?
Patent 8,513,263 protects VITRAKVI and is included in two NDAs.
This patent has one hundred and thirteen patent family members in thirty-nine countries.
Summary for Patent: 8,513,263
| Title: | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors |
| Abstract: | Compounds of Formula (I) in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor. |
| Inventor(s): | Julia Haas, Steven W. Andrews, Yutong Jiang, Gan Zhang |
| Assignee: | Array Biopharma Inc |
| Application Number: | US13/125,263 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,513,263
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-001 | Nov 26, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-002 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710-001 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,513,263
| PCT Information | |||
| PCT Filed | October 21, 2009 | PCT Application Number: | PCT/US2009/061519 |
| PCT Publication Date: | April 29, 2010 | PCT Publication Number: | WO2010/048314 |
International Family Members for US Patent 8,513,263
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3106463 | ⤷ Start Trial | 301033 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3106463 | ⤷ Start Trial | PA2020504 | Lithuania | ⤷ Start Trial |
| European Patent Office | 3106463 | ⤷ Start Trial | CA 2020 00013 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
